(1985). Treatment selection for cancer patients: application of statistical decision theory to the treatment of advanced ovarian cancer. Journal of chronic diseases, 38(2), 171-186.Simes RJ: Treatment selection for cancer patients: Application of statistical decision theory to the treatment of ...
Background: in advanced ovarian cancer, over the last 10 years no studies have demonstrated more appropriate therapeutic options compared to the current standard Carboplatin-Paclitaxel (Cb-P) regimen. Two phase III randomized studies (GOG-218 and ICON-7) have recently demonstrated the efficacy of ...
The addition of an investigational immunotherapy to chemotherapy prolonged survival for women with advanced ovarian cancer, according to a topline data announcement. IMNN-001 (Imunon Inc.) is an IL-12 DNA plasmid vector encased in a nanoparticle delivery system, according to a press release issue...
Efficacy and safety of dose-dense paclitaxel plus carboplatin as neoadjuvant chemotherapy for advanced ovarian, fallopian tube or peritoneal cancer. Interval debulking surgery (IDS) after neoadjuvant chemotherapy (NAC) is currently one of the preferred treatment options for advanced ovarian, fallopian t....
There are currently few effective treatment options for patients with recurrent ovarian cancer and other solid tumors, but City of Hope researchers are trying to change that. Ad Researchers with City of Hope, one of the largest cancer research and treatment organizations in the nation, have publish...
Treatment with the folate receptor α–directed antibody-drug conjugate luveltamab tazevibulin led to a 37.5% overall response rate in Frα-selected patients with advanced ovarian cancer, defined by a tumor proportion score above 25%.
“It’s exciting to have some new treatment options for women with ovarian cancer, and some options for maintenance that we have never had before,” Medlin said. Read CURE®’s original coverage on the approval of the combination of Lynparza and Avastin.Related...
Introduction: Although racial/ethnic disparities in ovarian cancer have been documented, factors contributing to the disparities need further research. This study examines whether racial/ethnic disparity in ovarian cancer diagnosis and treatment can be explained by individual-level factors, contextual-level ...
While it may be hard to have food duringcancer treatment, it’s important to try to keep abalanced diet. Have plenty of fluids, protein-rich foods, and nutritious options like smoothies in your diet. Ascites Ascitesis a buildup of fluid in your abdomen. It's a common symptom of advance...
A new combination of targeted drugs for a type of ovarian cancer has shown promising results in an early clinical trial—shrinking tumors in half of patients.